Theobromine From Cocoa and Cardiovascular Risk Factors

Last updated: March 16, 2026
Sponsor: Chiang Mai University
Overall Status: Completed

Phase

N/A

Condition

Williams Syndrome

Stress

Vascular Diseases

Treatment

white chocolate

dark chocolate

Clinical Study ID

NCT06820944
21/67
  • Ages 35-70
  • Male

Study Summary

The goal of this clinical trial is to examine whether consumption of dark chocolate affects blood pressure and a cardiovascular risk factor called trimethylamine N-oxide in Thai male participants with hypertension. The main questions it aims to answer are:

Can consumption of dark chocolate lower blood pressure? Can consumption of dark chocolate lower blood trimethylamine N-oxide?

Researchers will compare dark chocolate to white chocolate to see if the effects are due to theobromine (a key bioactive compound in dark chocolate).

Participants will consume either 100 g 72% dark chocolate bar or 80 g white chocolate bar daily for 14 days, rest for 7 days, and then switch to the other type of chocolate.

Eligibility Criteria

Inclusion

Inclusion criteria

  • Male

  • Age between 35 to 70 years

  • BMI less than 30 kg/m^2

  • Systolic blood pressure between 130 to 159 mmHg or Diastolic blood pressure between 85 to 99 mmHg.

  • Do not smoke.

Exclusion criteria

  • Cannot drink beverages and consume foods that have caffeine.

  • Take medicine to lower cholesterol and triglyceride levels, treat high blood pressure, or diabetes.

  • Have liver and kidney inflammation.

  • Use antibiotics within 1 month of study.

  • Use choline or probiotic supplements regularly within 1 month of study.

  • Consume more than 30 alcoholic drinks per week.

  • Have chronic diseases.

Study Design

Total Participants: 53
Treatment Group(s): 2
Primary Treatment: white chocolate
Phase:
Study Start date:
February 15, 2025
Estimated Completion Date:
April 30, 2025

Study Description

This is a randomized cross-over trial conducted in Chiang Mai, Thailand. The goal of this clinical trial is to examine whether consumption of dark chocolate affects cardiovascular risk factors, with the primary outcomes being blood pressure and a cardiovascular risk factor called trimethylamine N-oxide. Participants are Thai males aged 35-70 years with hypertension who live in the Chiang Mai area.

42 Participants will consume either 100 g 72% dark chocolate bar (2.5 servings, providing ~900 mg theobromine) or 80 g white chocolate bar (2 servings, providing 0 mg theobromine) daily for 14 days. After a 7-day wash-out period, the participant will repeat the protocol with the other intervention.

Connect with a study center

  • Research Institute for Health Sciences, Chiang Mai University

    Mueang, Chiang Mai 50200
    Thailand

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.